FDA Inspection
ESJAY Pharma PRIVATE LIMITEDESJAY Pharma PRIVATE LIMITED – FDA Inspection, Sep 1, 2026
Record Details
This FDA Inspection record concerns ESJAY Pharma PRIVATE LIMITED, with an inspection on September 1, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 1b195509-749c-415f-b2e2-80e1474d9c19
Inspection Facts
- Inspection number
- 1334246
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.166(a)(1)Sample size - test intervals
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ESJAY Pharma PRIVATE LIMITED
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 17, 2024 | Not classified | Office of Inspections and Investigations |
Other documents for ESJAY Pharma PRIVATE LIMITED
- FDA Inspection 1241926 - 2024-05-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.